Long‐term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical and Experimental Ophthalmology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ceo.12165PMID 23844601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.

  2013influential reference
• Gender Differences in Benign Essential Blepharospasm

  2012influential reference
• Long-Term Efficacy of Botulinum A Toxin for Blepharospasm and Hemifacial Spasm

  2010influential reference
• Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs

  2009influential reference
• Langzeittherapie fokaler Dystonien und des Hemispasmus facialis mit Botulinum-Toxin A

  2008cited by this paper
• [Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A].

  2008influential reference
• Botulinum toxin in the treatment of blepharospasm and hemifacial spasm

  2007influential reference
• Botulinum toxin in ophthalmology.

  2007cited by this paper
• Supramaximal doses of botulinum toxin for refractory blepharospasm.

  2006cited by this paper
• A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS‐ES Task Force

  2006cited by this paper
• Safety and efficacy of botulinum toxin type A following long‐term use

  2006influential reference
• Immunological aspects of Botox®, Dysport® and MyoblocTM/NeuroBloc®

  2006cited by this paper
• Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.

  2005influential reference
• Long‐term botulinum toxin efficacy, safety, and immunogenicity

  2005cited by this paper
• Different types of botulinum toxin in humans

  2004cited by this paper
• Botulinum toxin in clinical practice

  2004cited by this paper
• Clinical comparability of marketed formulations of botulinum toxin

  2004cited by this paper
• Basic immunological aspects of botulinum toxin therapy

  2004cited by this paper
• Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.

  2003influential reference
• Epidemiology of primary blepharospasm

  2002cited by this paper
• Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm

  2002cited by this paper
• Considering the Immune Response to Botulinum Toxin

  2002cited by this paper
• Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.

  2002influential reference
• Tetanus and botulinum neurotoxins: turning bad guys into good by research.

  2001cited by this paper
• [Botulinum toxin in ophthalmology].

  2001influential reference
• Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients.

  1996cited by this paper
• Botulinum toxin-A for the treatment of hemifacial spasm.

  1995cited by this paper
• [Hemifacial spasm treated with botulinum toxin].

  1993cited by this paper
• 'Ping-pong' gaze

  1992cited by this paper
• Effects of repeated botulinum toxin injections on orbicularis oculi muscle.

  1992cited by this paper
• Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.

  1988cited by this paper
• Botulinum toxin treatment of hemifacial spasm.

  1986cited by this paper
• Treatment of blepharospasm with botulinum toxin.

  1985cited by this paper
• The use of botulinum toxin in blepharospasm.

  1985cited by this paper
• Botulinum A toxin injection as a treatment for blepharospasm.

  1985cited by this paper
• Hemifacial spasm treated with botulinum A toxin injection.

  1985cited by this paper
• Blinking and blepharospasm. Mechanism, diagnosis, and management.

  1982cited by this paper
• Botulinum toxin injection of eye muscles to correct strabismus.

  1981cited by this paper
• Botulinum toxin injection of eye muscles to correct strabismus.

  1981cited by this paper
• Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.

  1980cited by this paper
• Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.

  1980cited by this paper
• Pharmacologic weakening of extraocular muscles.

  1973cited by this paper

• Botulinum toxin type A injections demonstrate remarkable efficacy in treating hemifacial spasm in elderly patients.

  2025cites this paper
• Hemifacial spasm in the Middle East: Insights from a high-volume tertiary care center.

  2025cites this paper
• Risk factors for Delayed Facial Palsy following Microvascular Decompression in Hemifacial Spasm: a systematic review and meta-analysis.

  2025cites this paper
• Surgical Interventions for the Management and Treatment of Chronic Migraine in Clinical Nursing Practice

  2025cites this paper
• Efficacy and Complications of Full Dose versus Half Dose of Botulinum Toxin Type A Injection in Benign Essential Blepharospasm

  2024cites this paper
• Botulinum toxin type A in scar treatment: Review article

  2024cites this paper
• Botulinum Toxin in Oculoplasty: An Overview

  2024cites this paper
• Botulinum toxin treatment for hemifacial spasm: harmonising neurological and aesthetic outcomes

  2024cites this paper
• Clinical implications of genetic polymorphisms in blepharospasm

  2024cites this paper
• Factors influencing short-term prognosis after botulinum toxin type A treatment for hemifacial spasm：A retrospective study

  2024cites this paper
• Association analyses between the variants of SNAP25, SV2C and ST3GAL2 and the efficacy of botulinum toxin A in the treatment of the primary Meige syndrome

  2024cites this paper
• Stable Convergent Polyneuronal Innervation and Altered Synapse Elimination in Orbicularis oculi Muscles from Patients with Blepharospasm Responding Poorly to Recurrent Botulinum Type-A Neurotoxin Injections

  2024cites this paper
• Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?

  2024cites this paper
• Efficacy and safety of botulinum neurotoxin in the treatment of hemifacial spasms: a systematic review and meta-analysis

  2024cites this paper
• Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache

  2023cites this paper
• Operative Findings of over 5000 Microvascular Decompression Surgeries for Hemifacial Spasm: Our Perspective and Current Updates

  2023cites this paper
• Effects of zinc supplementation on duration and action of botulinum toxin applied to face muscles: A systematic review of randomized clinical trials

  2023cites this paper
• Effects of Intradermal Botulinum Toxin Injections on Herpes Zoster Related Neuralgia

  2023cites this paper
• Incidence and prevalence of Hemifacial Spasm in Finland's largest hospital district.

  2023cites this paper
• Mechanism and clinical use of botulinum neurotoxin in head and facial region.

  2023cites this paper
• Comprehensive Korean Medicine Treatment for Benign Essential Blepharospasm in a Patient Responding Poorly to Botulinum Toxin Treatment

  2022cites this paper
• Classification of Dystonia

  2022cites this paper
• Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication

  2022cites this paper
• Patient-reported outcomes following a break in ophthalmic botulinum toxin therapy during the COVID-19 pandemic

  2022cites this paper
• Bolu Abant İzzet Baysal Üniversitesi Nöroloji Kliniğinde Botulinum Toksin Uygulamaları Deneyimleri

  2022cites this paper
• Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis

  2022cites this paper
• Botulinum neurotoxin for the treatment of movement disorders: Practical considerations

  2022cites this paper
• Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center

  2022influential citation
• Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm

  2021cites this paper
• Peripheral movement disorders

  2021cites this paper
• A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm

  2021cites this paper
• Complications of Preseptal Versus Pretarsal Botulinum Toxin Injection in Benign Essential Blepharospasm: A Randomized Controlled Trial.

  2021cites this paper
• Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies

  2021cites this paper
• Antibody Development in Patients Treated Long-Term With OnabotulinumtoxinA for Benign Essential Blepharospasm and Hemifacial Spasm

  2021influential citation
• Posterior ocular structural changes and glaucoma susceptibility in patients with hemifacial spasm

  2021cites this paper
• Non-aesthetic uses of botulinum toxin in the head and neck

  2021cites this paper
• Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose

  2021cites this paper
• Auditory-Perceptual Evaluation of Deep Brain Stimulation on Voice and Speech in Patients With Dystonia.

  2020cites this paper
• Switchover study of onabotulinumtoxinA to incobotulinumtoxinA for facial dystonia

  2020influential citation
• The good toxin: 10 years of experience with botulinum toxin A in the treatment of benign essential blepharospasm

  2020cites this paper
• Drugs in the Treatment of Dystonia, Multisystem Atrophy, and Non-Parkinson Tremor

  2020cites this paper
• Surgical Outcome of Microvascular Decompression for Hemifacial Spasm: Symptom Control and Quality of Life

  2020cites this paper
• Botulinum toxin type A therapy for hemifacial spasm.

  2020cites this paper
• Use of Botulinum Toxin in Ophthalmology

  2020cites this paper
• Overview of Hemifacial Spasm

  2020cites this paper
• BTX-A Promotes Expression of Angiogenesis-Associated Genes in Human Umbilical Vein Endothelial Cells

  2020cites this paper
• Evidence-Based Review of Current Botulinum Toxin Treatment Indications in Medicine

  2020cites this paper
• Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine

  2020influential citation
• The Therapeutic Use of Botulinum Toxin Injections for Conditions Affecting the Head and Neck

  2020cites this paper
• Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia

  2020cites this paper
• Treatment of blepharospasm and Meige’s syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice

  2019cites this paper
• Dry Eye Syndrome Preferred Practice Pattern®.

  2019cites this paper
• Treatment of Keloid Scars with Botulinum Toxin Type A versus Triamcinolone in an Athymic Nude Mouse Model

  2019cites this paper
• A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change

  2019cites this paper
• Profile of botulinum toxin injections in a neurology outpatient service Hospital: A preliminary report

  2019cites this paper
• Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China

  2019cites this paper
• Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment

  2019cites this paper
• Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm

  2018cites this paper
• Effect of Hemifacial Spasm on Intraocular Pressure Measurement

  2018cites this paper
• Benign Essential Blepharospasm: What We Know and What We Don’t

  2018cites this paper
• Dry Eye Syndrome Preferred Practice Pattern ® Dry Eye PPP Secretary for Quality of Care

  2018cites this paper
• Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm

  2018cites this paper
• Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia

  2018cites this paper
• Can botulinum toxin cause chronic muscle weakness?

  2018cites this paper
• Why Neurotoxin Treatment is Generally Safe? What is the Long-Term Efficacy

  2018cites this paper
• Complications of Botulinum Toxin A: A Comprehensive Review

  2018cites this paper
• Botulinum Toxin Treatment of Movement Disorders

  2018cites this paper
• Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm

  2018cites this paper
• Treatment of Blepharospasm/Hemifacial Spasm

  2017cites this paper
• Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation

  2017influential citation
• Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa

  2017cites this paper
• A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques

  2017cites this paper
• Retracción palpebral en ojo contralateral: poscirugía de ptosis palpebral

  2017cites this paper
• Systematic analysis of botulinum neurotoxin type A immunogenicity in clinical studies

  2017cites this paper
• Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia

  2016cites this paper
• How Useful are Localization Techniques in Botulinum Toxin Injections for Dystonia and Spasticity Indications

  2016cites this paper
• Painful tic convulsif: Case series and literature review

  2016cites this paper
• Deep Brain Stimulation for Craniocervical Dystonia (Meige Syndrome): A Report of Four Patients and a Literature‐Based Analysis of Its Treatment Effects

  2016cites this paper
• Applications of Botulinum Toxin in Dentistry-Literature

  2016cites this paper
• Impact of botulinum toxin‐A on corneal curvature assessed with Scheimpflug and Placido systems

  2016cites this paper
• Long-term facial improvement after repeated BoNT-A injections and mirror biofeedback exercises for chronic facial synkinesis: a case-series study.

  2016cites this paper
• History of Botulinum Toxin Treatment in Movement Disorders

  2016cites this paper
• A Survey of Current Blepharospasm Treatment Patterns Among Oculoplastic Surgeons

  2016cites this paper
• Differences in Corneal Parameters Between Affected and Normal Contralateral Eyes in Patients With Hemifacial Spasm Treated With Botulinum Toxin-A: Outcomes During One Complete Treatment Cycle

  2016cites this paper
• Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm

  2016cites this paper
• Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment

  2016cites this paper
• Use of Botulinum Neurotoxin in Ophthalmology

  2016cites this paper
• [Painful tic convulsif: Case series and literature review].

  2016cites this paper
• Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®

  2015influential citation
• Hemifacial spasm: The past, present and future.

  2015cites this paper
• Minimally invasive eyelid care in dermatology: medical, laser, and cosmetic therapies.

  2015cites this paper
• Long-Term Effect of Botulinum Toxin in the Treatment of Benign Essential Blepharospasm and Hemifacial Spasm

  2015cites this paper
• Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: A retrospective analysis in 101 patients

  2015cites this paper
• Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential Blepharospasm

  2015cites this paper
• Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.

  2015cites this paper
• Use of botulinum toxin injections to treat peripheral stimulator induced facial muscle twitching: a case report

  2015cites this paper
• Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm

  2015cites this paper
• Wiederholte Injektionen von Botulinumtoxin Typ A steigern kontinuierlich die Wirkdauer bei primärer axillärer Hyperhidrose: Eine retrospektive Analyse von 101 Patienten

  2015cites this paper
• Resultados del tratamiento de las distonías focales en el adulto con el uso de toxina botulínica A3

  2015cites this paper
• Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis

  2014cites this paper